Literature DB >> 22605604

'Fungal spondylodiscitis in a non-immunocompromised patient'.

Vanda Cristina Jorge1, Catarina Cardoso, Carla Noronha, José Simões, Nuno Riso, Manuel Vaz Riscado.   

Abstract

Spondylodiscitis is an inflammatory disease, usually infectious, of one or more vertebral bodies and of corresponding intervertebral discs. The fungal aetiology is rare (less than 5% of cases), affecting mostly immunocompromised individuals. It is often a delayed diagnosis by the indolence of symptoms, presenting itself as a serious infection, which may result in important functional consequences. The authors present the case of a 75-year-old male, with constitutional complaints and intense back pain. Prior recent history of left hemicolectomy due to diverticulitis with multiple surgical complications, resulted in prolonged intensive care unit hospitalisation, and, later on, an episode of fungal endophthalmitis. The diagnosis of spondylodiscitis L5/S1 was performed by MRI. The patient underwent surgical disco-vertebral debridement and isolation of a Candida albicans was seen in the collected surgical material. No evidence of an immunossupressive status was found. Treatment was complemented with liposomal amphotericin B in the maximum recommended dose.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605604      PMCID: PMC3316868          DOI: 10.1136/bcr.12.2011.5337

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

Review 1.  Spinal and spinal cord infection.

Authors:  Danielle L Balériaux; Carine Neugroschl
Journal:  Eur Radiol       Date:  2004-03       Impact factor: 5.315

Review 2.  Non-pyogenic infections of the spine.

Authors:  Ghassan S Skaf; Zeina A Kanafani; George F Araj; Souha S Kanj
Journal:  Int J Antimicrob Agents       Date:  2010-05-21       Impact factor: 5.283

Review 3.  Endophthalmitis caused by non-albicans species of Candida.

Authors:  N Joshi; B H Hamory
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

Review 4.  Candidal vertebral osteomyelitis: report of 6 patients, and a review.

Authors:  L Hendrickx; E Van Wijngaerden; I Samson; W E Peetermans
Journal:  Clin Infect Dis       Date:  2001-02-06       Impact factor: 9.079

5.  A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features.

Authors:  C D'Agostino; L Scorzolini; A P Massetti; M Carnevalini; G d'Ettorre; M Venditti; V Vullo; G B Orsi
Journal:  Infection       Date:  2010-02-27       Impact factor: 3.553

6.  Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.

Authors:  Javier Pemán; Isidro Jarque; María Bosch; Emilia Cantón; Miguel Salavert; Rosario de Llanos; Araceli Molina
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

7.  [Spondylodiskitis caused by Candida albicans. Report of two new cases].

Authors:  F L Lado Lado; I Villamil Cajoto; I Rodríguez Constenla; E Van den Eyne Otero; A Prieto Martínez
Journal:  An Med Interna       Date:  2005-02

8.  Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use.

Authors:  M F Parry; B Grant; M Yukna; D Adler-Klein; G X McLeod; R Taddonio; C Rosenstein
Journal:  Clin Infect Dis       Date:  2001-01-24       Impact factor: 9.079

9.  Spontaneous pyogenic vertebral osteomyelitis in nondrug users.

Authors:  Joan M Nolla; Javier Ariza; Carmen Gómez-Vaquero; Jordi Fiter; Joaquín Bermejo; Josep Valverde; Daniel Roig Escofet; Francesc Gudiol
Journal:  Semin Arthritis Rheum       Date:  2002-02       Impact factor: 5.532

Review 10.  Osteomyelitis.

Authors:  Daniel P Lew; Francis A Waldvogel
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

View more
  1 in total

1.  Quantitative B-lymphocyte deficiency and increased TCRγδ T-lymphocytes in acute infectious spondylodiscitis.

Authors:  Anna K Haugaard; Hanne V Marquart; Lilian Kolte; Lars Peter Ryder; Michala Kehrer; Maria Krogstrup; Ulrik B Dragsted; Benny Dahl; Ida E Gjørup; Åse B Andersen; Peter Garred; Susanne D Nielsen
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.